<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03037957</url>
  </required_header>
  <id_info>
    <org_study_id>LMA-GAS-01-CS-006</org_study_id>
    <nct_id>NCT03037957</nct_id>
  </id_info>
  <brief_title>A Multi-Site Clinical Evaluation of the ARIES Group A Strep Assay in Symptomatic Patients</brief_title>
  <official_title>A Multi-Site Clinical Evaluation of the ARIES Group A Strep Assay in Symptomatic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Luminex Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Luminex Molecular Diagnostics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A multi-center evaluation to assess the diagnostic sensitivity and specificity of the ARIES
      Group A Strep Assay will be established through a method comparison using prospectively
      collected, de-identified, clinical samples collected during the enrollment period.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 9, 2017</start_date>
  <completion_date type="Actual">June 2, 2017</completion_date>
  <primary_completion_date type="Actual">June 2, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical performance (sensitivity/specificity) for Group A Strep Assay</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">704</enrollment>
  <condition>Pharyngitis Bacterial</condition>
  <arm_group>
    <arm_group_label>Group A Strep Assay</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ARIES Group A Strep Assay</intervention_name>
    <arm_group_label>Group A Strep Assay</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients presenting with signs and symptoms of pharyngitis for which their doctors ordered
        a Group A Strep test.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient and/or patient's legal guardian is willing and able to give informed consent
             and/or assent for extra research sample.

          -  The subject's specimen is a throat swab in Liquid Amies based transport medium.

          -  The specimen is from an adult or pediatric, male or female subject who is either
             hospitalized, admitted to a hospital emergency department, visiting an outpatient
             clinical or resident of a long term care facility.

          -  The specimen is from a patient for whom a requisition has been made for Group A Strep
             testing

          -  The specimen is from a patient exhibiting clinical signs and symptoms of pharyngitis
             consistent with Group A Strep infection.

          -  The specimen was received in good condition (no leakage or drying of the specimen).

          -  The specimen volume is ≥ 850 µL.

        Exclusion Criteria:

          -  The specimen is from a patient who did not provide informed consent/assent.

          -  The specimen is not a throat swab collected in Liquid Amies based transport medium.

          -  The specimen is from a patient who is undergoing antibiotic treatment.

          -  The specimen was not properly collected, transported, processed or stored according to
             the instructions provided by the Sponsor in Section 9 below.

          -  The specimen volume is &lt; 850 µL.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronald Dunn</last_name>
    <role>Study Director</role>
    <affiliation>Luminex Corporation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Hospital Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sacred Heart Hospital</name>
      <address>
        <city>Pensacola</city>
        <state>Florida</state>
        <zip>32504</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Mercy Hospital</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>54449</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advanced Pediatrics Research</name>
      <address>
        <city>Vienna</city>
        <state>Virginia</state>
        <zip>22180</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marshfield Labs</name>
      <address>
        <city>Marshfield</city>
        <state>Wisconsin</state>
        <zip>54449</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 3, 2017</study_first_submitted>
  <study_first_submitted_qc>January 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 31, 2017</study_first_posted>
  <last_update_submitted>July 5, 2017</last_update_submitted>
  <last_update_submitted_qc>July 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharyngitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

